2020 MIPS Extreme and Uncontrollable Circumstances Exception Application Deadline has been Extended to February 1, 2021

December 8, 2020

To further support clinicians during the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services (CMS) is extending the 2020 Merit-based Incentive Payment System (MIPS) Extreme and Uncontrollable Circumstances Exception application deadline to February 1, 2021.

For the 2020 performance year, CMS will be using its Extreme and Uncontrollable Circumstances policy to allow MIPS eligible clinicians, groups, and virtual groups to submit an application requesting reweighting of one or more MIPS performance categories to 0% due to the current COVID-19 public health emergency.

MIPS participants with concerns about the effect of the COVID-19 public health emergency on performance data, including cost measures, for the 2020 performance period, may submit an application now—COVID-19 must be cited as the reason for the application.

Participants with approved applications can still receive scores for the Quality, Improvement Activities and Promoting Interoperability performance categories data is submitted. If the Cost performance category is included in approved applications, participants will not be scored on cost measures even if other data are submitted. Learn more in the 2020 Exceptions Applications Fact Sheet.

APM Entities may also apply to reweight MIPS performance categories as a result of extreme and uncontrollable circumstances, such as the public health emergency resulting from the COVID-19 pandemic. Learn more in the 2021 Quality Payment Program Final Rule Overview Fact Sheet.

The deadline for the Promoting Interoperability Hardship Exception application will remain December 31, 2020. Remember, if you’re already exempt from reporting Promoting Interoperability data, you don’t need to apply for the Uncontrollable Circumstances Exception.

Contact the Quality Payment Program at 1-866-288-8292 or QPP@cms.hhs.gov for further assistance.

Bookmark ASCO in Action for additional news, advocacy, and analysis on cancer policy.